These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 33669630)
1. LOXL2 Inhibitors and Breast Cancer Progression. Ferreira S; Saraiva N; Rijo P; Fernandes AS Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33669630 [TBL] [Abstract][Full Text] [Related]
2. Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis. Ramos S; Ferreira S; Fernandes AS; Saraiva N Front Pharmacol; 2022; 13():883998. PubMed ID: 35800439 [TBL] [Abstract][Full Text] [Related]
3. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247 [TBL] [Abstract][Full Text] [Related]
4. LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer. Di Mauro P; Croset M; Bouazza L; Clézardin P; Reynaud C J Bone Oncol; 2024 Feb; 44():100522. PubMed ID: 38283827 [TBL] [Abstract][Full Text] [Related]
5. Purification of enzymatically active human lysyl oxidase and lysyl oxidase-like protein from Escherichia coli inclusion bodies. Jung ST; Kim MS; Seo JY; Kim HC; Kim Y Protein Expr Purif; 2003 Oct; 31(2):240-6. PubMed ID: 14550642 [TBL] [Abstract][Full Text] [Related]
6. The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin. Kim YM; Kim EC; Kim Y Mol Biol Rep; 2011 Jan; 38(1):145-9. PubMed ID: 20306300 [TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. Vallet SD; Ricard-Blum S Essays Biochem; 2019 Sep; 63(3):349-364. PubMed ID: 31488698 [TBL] [Abstract][Full Text] [Related]
9. A molecular role for lysyl oxidase in breast cancer invasion. Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058 [TBL] [Abstract][Full Text] [Related]
10. Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer. Chang J; Lucas MC; Leonte LE; Garcia-Montolio M; Singh LB; Findlay AD; Deodhar M; Foot JS; Jarolimek W; Timpson P; Erler JT; Cox TR Oncotarget; 2017 Apr; 8(16):26066-26078. PubMed ID: 28199967 [TBL] [Abstract][Full Text] [Related]
12. Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples. Janyasupab M; Lee YH; Zhang Y; Liu CW; Cai J; Popa A; Samia AC; Wang KW; Xu J; Hu CC; Wendt MK; Schiemann BJ; Thompson CL; Yen Y; Schiemann WP; Liu CC Recent Pat Biomark; 2015; 5(2):93-100. PubMed ID: 28670509 [TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation. Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451 [TBL] [Abstract][Full Text] [Related]
14. Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX. Hutchinson JH; Rowbottom MW; Lonergan D; Darlington J; Prodanovich P; King CD; Evans JF; Bain G ACS Med Chem Lett; 2017 Apr; 8(4):423-427. PubMed ID: 28435530 [TBL] [Abstract][Full Text] [Related]
15. Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression. Liburkin-Dan T; Toledano S; Neufeld G Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682926 [TBL] [Abstract][Full Text] [Related]
16. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis. Chen W; Yang A; Jia J; Popov YV; Schuppan D; You H Hepatology; 2020 Aug; 72(2):729-741. PubMed ID: 32176358 [TBL] [Abstract][Full Text] [Related]